CA Patent

CA2767993C — Composition and process for production thereof

Assigned to Sunstar Giken KK · Expires 2018-06-26 · 8y expired

What this patent protects

Disclosed are: a composition which enables the more effective development of the efficacy of a water-soluble drug in a solution containing the drug; and a dispersion in which a hydrophobic drug can be dispersed stably without requiring the use of any surfactant. Specifically disc…

USPTO Abstract

Disclosed are: a composition which enables the more effective development of the efficacy of a water-soluble drug in a solution containing the drug; and a dispersion in which a hydrophobic drug can be dispersed stably without requiring the use of any surfactant. Specifically disclosed are: a composition comprising ultra-fine bubbles having a mode particle size of 500 nm or less, a drug and water; and a process for producing a composition comprising ultra-fine bubbles haying a mode particle size of 500 nm or less, a drug and water, which utilizes an ultra-fine bubble generation apparatus.

Drugs covered by this patent

Patent Metadata

Patent number
CA2767993C
Jurisdiction
CA
Classification
—
Expires
2018-06-26
Drug substance claim
No
Drug product claim
No
Assignee
Sunstar Giken KK
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.